Hypoglycaemia: difference between revisions
Diff·revision 17 → 18·02:47, 15 Sep 2025
Difference between revision 17 and revision 18 of Hypoglycaemia. 2 lines changed; the page grew by 56 bytes.
| Revision 17 — 09:54, 19 Aug 2025 LabRangeLindy (talk) add the note that titration exists partly to manage these effects 4,417 bytes ±0 | Revision 18 — 02:47, 15 Sep 2025 AmylinAmos (talk) rm a duplicated category 4,473 bytes +56 | ||
|---|---|---|---|
| 37 | The relevant general point is that the glucose-dependence argument is a property of receptor pharmacology and does not extend to a preparation of unknown identity or content. A material whose actual peptide mass is unknown — see [[Peptide content]] and [[Underfilling]] — cannot be reasoned about pharmacologically at all, because the exposure is unknown.{{r|drucker2018}} | 37 | The relevant general point is that the glucose-dependence argument is a property of receptor pharmacology and does not extend to a preparation of unknown identity or content. A material whose actual peptide mass is unknown — see [[Peptide content]] and [[Underfilling]] — cannot be reasoned about pharmacologically at all, because the exposure is unknown.{{r|drucker2018}} |
| 38 | 38 | ||
| + | 39 | Nothing on this wiki is medical advice.{{r|nauck2016}} | |
| + | 40 | ||
| 39 | == References == | 41 | == References == |
| 40 | {{reflist}} | 42 | {{reflist}} |